Hollifield et al. reported a significantly lowered TGF-β and IFN-γ, IL-1β, T-cell mitogen (PHA), and myelin basic protein in peripheral blood mononuclear cells (PBMC) of remitted MS patients [54]. This evidence concerns the gene MBP and myeloid sarcoma.